• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻(≤40岁)女性同侧乳腺肿瘤浸润性复发是否比其原发肿瘤更具侵袭性?

Are ipsilateral breast tumour invasive recurrences in young (< or =40 years) women more aggressive than their primary tumours?

作者信息

Sigal-Zafrani B, Bollet M A, Antoni G, Savignoni A, Vincent-Salomon A, Pierga J-Y, Salmon R, Sastre-Garau X, Fourquet A

机构信息

Department of Pathology, Institut Curie, Paris, France.

出版信息

Br J Cancer. 2007 Oct 22;97(8):1046-52. doi: 10.1038/sj.bjc.6603991. Epub 2007 Sep 18.

DOI:10.1038/sj.bjc.6603991
PMID:17876326
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2360440/
Abstract

The characteristics of ipsilateral breast tumour recurrences (IBTRs) relative to those of their primary tumours (PTs) remain scarcely studied. Of 70 young (< or =40 years) premenopausal women with IBTRs, we studied a series of 63 with paired histological data. Median follow-up since IBTR was 10 years. Rates of histological types, grades or hormonal receptors were not significantly different in PTs and in IBTRs. The concordance between IBTRs and their PTs was good for histological types. IBTRs with conserved histological types tended to occur more locally, but not significantly sooner than others. These IBTRs had good concordance for hormone receptors. In discordant cases there were as many losses as appearances of the receptors. The concordance was weak for grades, with equivalent numbers of IBTRs graded lower as higher than their PTs. The 10-year overall survival rate was 70%. Neither the conservation of histological type, location, nor of the two combined were associated with deaths. Early (<2 years) IBTRs, tended to be associated with poorer survival (HR=2.24 (0.92-5.41); P=0.08). IBTRs did not display features of higher aggressiveness than PTs. Neither clinical nor histological definition of a true recurrence could be established other than the conservation of the histological type.

摘要

相对于原发肿瘤(PT),同侧乳腺肿瘤复发(IBTR)的特征鲜有研究。在70例患有IBTR的年轻(≤40岁)绝经前女性中,我们研究了一组63例具有配对组织学数据的患者。自IBTR以来的中位随访时间为10年。PT和IBTR在组织学类型、分级或激素受体方面的发生率无显著差异。IBTR与其PT在组织学类型方面的一致性良好。组织学类型保留的IBTR往往更倾向于局部发生,但并不比其他IBTR显著更早出现。这些IBTR在激素受体方面具有良好的一致性。在不一致的病例中,受体丢失和出现的数量相同。分级方面的一致性较弱,IBTR分级低于或高于其PT的数量相当。10年总生存率为70%。组织学类型、位置的保留,或两者的组合均与死亡无关。早期(<2年)IBTR往往与较差的生存率相关(HR=2.24(0.92-5.41);P=0.08)。IBTR未表现出比PT更高侵袭性的特征。除了组织学类型的保留外,无法确定真正复发的临床或组织学定义。

相似文献

1
Are ipsilateral breast tumour invasive recurrences in young (< or =40 years) women more aggressive than their primary tumours?年轻(≤40岁)女性同侧乳腺肿瘤浸润性复发是否比其原发肿瘤更具侵袭性?
Br J Cancer. 2007 Oct 22;97(8):1046-52. doi: 10.1038/sj.bjc.6603991. Epub 2007 Sep 18.
2
The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy.使用分子检测来明确保乳治疗的早期乳腺癌患者同侧乳腺肿瘤复发的克隆性及乳腺内复发模式。
Cancer. 2007 Apr 1;109(7):1264-72. doi: 10.1002/cncr.22529.
3
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ.国家乳腺与肠道外科辅助治疗项目的病理研究结果:关于小叶原位癌的12年观察
Cancer. 2004 Jan 15;100(2):238-44. doi: 10.1002/cncr.11883.
4
Long-term patterns of in-breast failure in patients with early stage breast cancer treated with breast-conserving therapy: a molecular based clonality evaluation.早期乳腺癌保乳治疗患者的乳房内失败长期模式:基于分子的克隆性评估。
Am J Clin Oncol. 2010 Feb;33(1):17-22. doi: 10.1097/COC.0b013e31819cccc3.
5
Factors predicting in-breast tumor recurrence after breast-conserving surgery.保乳手术后乳腺肿瘤复发的预测因素。
Breast Cancer Res Treat. 2009 Jul;116(1):171-7. doi: 10.1007/s10549-008-0187-y. Epub 2008 Sep 25.
6
Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.使用五生物标志物组合预测早期浸润性乳腺癌保乳治疗后的局部复发、远处转移和死亡情况。
J Clin Oncol. 2009 Oct 1;27(28):4701-8. doi: 10.1200/JCO.2008.21.7075. Epub 2009 Aug 31.
7
Patterns and predictors of early recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.雌激素受体阳性早期乳腺癌绝经后女性早期复发的模式及预测因素
Breast Cancer Res Treat. 2009 Sep;117(1):91-8. doi: 10.1007/s10549-008-0291-z. Epub 2008 Dec 27.
8
Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.瑞典东南部I期乳腺癌女性患者生存率提高:辅助性全身治疗使用增加前后两个时间段的比较
Acta Oncol. 2009;48(4):504-13. doi: 10.1080/02841860902718754.
9
Basal-HER2 phenotype shows poorer survival than basal-like phenotype in hormone receptor-negative invasive breast cancers.在激素受体阴性浸润性乳腺癌中,基底-HER2表型的生存率低于基底样表型。
Hum Pathol. 2008 Feb;39(2):167-74. doi: 10.1016/j.humpath.2007.06.012. Epub 2007 Nov 28.
10
Pattern of metastatic spread in triple-negative breast cancer.三阴性乳腺癌的转移扩散模式。
Breast Cancer Res Treat. 2009 May;115(2):423-8. doi: 10.1007/s10549-008-0086-2. Epub 2008 Jun 10.

本文引用的文献

1
The use of molecular assays to establish definitively the clonality of ipsilateral breast tumor recurrences and patterns of in-breast failure in patients with early-stage breast cancer treated with breast-conserving therapy.使用分子检测来明确保乳治疗的早期乳腺癌患者同侧乳腺肿瘤复发的克隆性及乳腺内复发模式。
Cancer. 2007 Apr 1;109(7):1264-72. doi: 10.1002/cncr.22529.
2
Age remains the first prognostic factor for loco-regional breast cancer recurrence in young (<40 years) women treated with breast conserving surgery first.年龄仍然是首次接受保乳手术治疗的年轻(<40岁)女性局部区域乳腺癌复发的首要预后因素。
Radiother Oncol. 2007 Mar;82(3):272-80. doi: 10.1016/j.radonc.2007.01.001. Epub 2007 Feb 6.
3
Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.年龄和放疗剂量对保乳治疗后局部控制的影响:欧洲癌症研究与治疗组织(EORTC)22881-10882试验
Radiother Oncol. 2007 Mar;82(3):265-71. doi: 10.1016/j.radonc.2006.09.014. Epub 2006 Nov 28.
4
Predicting a local recurrence after breast-conserving therapy by gene expression profiling.通过基因表达谱预测保乳治疗后的局部复发
Breast Cancer Res. 2006;8(5):R62. doi: 10.1186/bcr1614.
5
Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.保乳治疗后有局部复发高风险患者的原发性乳腺癌基因表达谱
Clin Cancer Res. 2006 Oct 1;12(19):5705-12. doi: 10.1158/1078-0432.CCR-06-0805.
6
The impact of young age on locoregional recurrence after doxorubicin-based breast conservation therapy in patients 40 years old or younger: How young is "young"?40岁及以下患者接受基于阿霉素的保乳治疗后,年轻对局部区域复发的影响:多年轻才算“年轻”?
Int J Radiat Oncol Biol Phys. 2006 Aug 1;65(5):1345-52. doi: 10.1016/j.ijrobp.2006.03.028. Epub 2006 Jun 5.
7
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.早期乳腺癌放疗及手术范围差异对局部复发和15年生存率的影响:随机试验综述
Lancet. 2005 Dec 17;366(9503):2087-106. doi: 10.1016/S0140-6736(05)67887-7.
8
Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors.保乳治疗后浸润性乳腺癌同侧复发的分子克隆性测定:与临床和生物学因素的比较
Am J Clin Pathol. 2005 May;123(5):679-89.
9
Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.基于真性复发和新发原发性肿瘤分类的保乳治疗后同侧乳腺肿瘤复发分析
Breast Cancer. 2005;12(2):104-11. doi: 10.2325/jbcs.12.104.
10
Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy.
Eur J Cancer. 2004 Jul;40(10):1502-8. doi: 10.1016/j.ejca.2004.03.014.